Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100074
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
2004-12-22
Brief Title:
To Assess the Safety and Tolerability of 75 15 and 30 mg of Sublingual Lobeline - 1
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Safety and Tolerability Study of Sublingual Lobeline
Status:
UNKNOWN
Status Verified Date:
2004-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the safety and tolerability of 75 15 and 30 mg of sublingual lobeline
Detailed Description:
The primary objective of this study is to characterize the pharmacokinetics of three ascending doses of lobeline in normal volunteers
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None